News

The generosity of HRI UK supporters has enabled the purchase of two cutting-edge microscopes that will help speed our cardiovascular disease research to the next breakthrough.

HRI spoke to Channel 9 News Health Reporter Gabriella Rogers about how a breakthrough anti-clotting drug is poised to enter Phase 2 clinical trials to improve the quality of life for thousands of stroke sufferers.

Professor Willem Ouwehand, Professor of Experimental Haematology at the University of Cambridge and at the Sanger Institute speaks to Professor Ben Freedman, Deputy Director Research Strategy and Group Leader at HRI about the state of heart disease research in the UK and the potential for research collaborations.

Originally from Ireland, Dr John O’Sullivan has been awarded a grant under the NSW Government’s transformative $150 million investment in cardiovascular research.

The Heart Research Institute UK is pleased to announce the award of two inaugural Acceleration Grants to Dr Anna Waterhouse, leader of the Cardiovascular Medical Devices Group and to Dr John O’Sullivan, leader of the Cardiometabolic Disease Group.

Some of the best research comes from the sharing of ideas, skills and experiences. Between scientists, between facilities – and between countries.

In March, HRI celebrated 30 years of groundbreaking research and new discoveries that have contributed to an improved understanding of cardiovascular disease.

HRI’s Dr Anna Waterhouse joined Professor Paul Weiss from UCLA and Dr Shelley Wickham from The University of Sydney, Schools of Chemistry and Physics, to discuss nanoscience and taking health and medicine to the next level at a public lecture held by Sydney Ideas together with The University of Sydney Nano Institute.

Every three hours, one Australian has a limb amputated due to cardiovascular disease.